サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1675643

バイオテクノロジー試薬市場：技術別、用途別、地域別、2025-2033年

Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 147 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
バイオテクノロジー試薬市場：技術別、用途別、地域別、2025-2033年
出版日: 2025年03月01日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオテクノロジー試薬市場の世界市場規模は、2024年に917億4,800万米ドルに達しました。今後、IMARC Groupは、2033年には1,747億3,540万米ドルに達し、2025～2033年の成長率（CAGR）は7.05％になると予測しています。同市場は、研究開発（R&D）活動への投資の増加、ヘルスケア診断と医薬品開発における需要の高まり、慢性疾患と遺伝性疾患の流行の高まり、生産と自動化における急速な技術進歩に牽引され、力強い成長を遂げています。

バイオテクノロジー試薬は、ライフサイエンス分野で極めて重要な役割を果たし、様々な研究や診断アプリケーションを促進します。試薬は、生物学的分子やシステムの単離、分析、操作を可能にするバイオテクノロジープロセスで使用される重要なコンポーネントです。これらは細心の製造工程を経て製造され、正確で信頼性の高い結果を提供するよう設計されており、実験や調査の進展と成功を確実なものにしています。バイオテクノロジー試薬の主な利点のひとつは、その多用途性とライフサイエンスにおける複数の分野にわたる幅広い適用性です。バイオテクノロジー試薬は、デオキシリボ核酸（DNA）、リボ核酸（RNA）、タンパク質の抽出・精製、アッセイの実施、バイオマーカーの検出、遺伝子発現研究の実施などを可能にするため、ゲノミクス、プロテオミクス、細胞生物学、分子診断学、創薬などの様々な研究分野で活用されています。バイオテクノロジー試薬はまた、新しい治療薬、ワクチン、個別化医薬品の開発を促進し、ヘルスケアと病気の治療の進歩に貢献しています。

バイオテクノロジー試薬市場の動向：

世界のバイオテクノロジー試薬市場は、ライフサイエンス分野における研究開発（R&D）活動の増加、個別化医療や標的治療に対する需要の高まりなど、多くの要因によって支えられています。さらに、ゲノミクスやプロテオミクス研究の急速な進展、慢性疾患や感染症の急増が市場の成長を加速させています。このほか、バイオテクノロジーと分子生物学の技術的進歩、製薬・バイオテクノロジー産業の拡大も市場成長に弾みをつけています。さらに、医療インフラへの投資の急増、政府のイニシアティブ、研究プロジェクトへの資金提供なども成長を促す要因となっています。これに伴い、学術機関と業界各社との共同研究が活発化し、分子診断薬に対する認識と採用が高まっていることも、市場の成長を後押ししています。さらに、バイオインフォマティクスや計算生物学の台頭、バイオバンクやバイオリポジトリ施設の拡大も市場成長を後押ししています。その他、正確な実験結果を得るための高品質な試薬に対する需要の急増、農業における遺伝子組み換え作物（GMO）に対する需要の高まり、CRISPR/Cas9遺伝子編集などの新たな用途に向けた新規試薬の開発などが、市場成長にプラスに寄与しています。

本レポートで扱う主な質問

  • 世界のバイオテクノロジー試薬市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界のバイオテクノロジー試薬市場における促進要因、抑制要因、機会は何か？
  • 各促進要因、抑制要因、機会が世界のバイオテクノロジー試薬市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的なバイオテクノロジー試薬市場はどの国か？
  • 技術別の市場内訳は？
  • バイオテクノロジー試薬市場で最も魅力的な技術は何か？
  • 用途別の市場内訳は？
  • バイオテクノロジー試薬市場で最も魅力的な用途は？
  • 市場の競合構造は？
  • 世界のバイオテクノロジー試薬市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のバイオテクノロジー試薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：技術別

  • ライフサイエンス試薬
    • 主要セグメント
      • PCR
      • 細胞培養
      • 血液学
      • 体外診断
      • その他
  • 分析試薬
    • 主要セグメント
      • クロマトグラフィー
      • 質量分析
      • 電気泳動
      • フローサイトメトリー
      • その他

第7章 市場内訳：用途別

  • タンパク質合成・精製
  • 遺伝子発現
  • DNA・RNA解析
  • 薬物検査
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第9章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Beckman Coulter Inc.（Danaher Corporation）
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Illumina Inc.
    • Lonza Group AG
    • Merck KGaA
    • Meridian Bioscience Inc.（SD Biosensor）
    • PerkinElmer Inc.
    • Promega Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Biotechnology Reagents Market: Major Drivers and Challenges
  • Figure 2: Global: Biotechnology Reagents Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Biotechnology Reagents Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Biotechnology Reagents Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Biotechnology Reagents Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Biotechnology Reagents (Life Science Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Biotechnology Reagents (Life Science Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Biotechnology Reagents (Analytical Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Biotechnology Reagents (Analytical Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Biotechnology Reagents (Protein Synthesis and Purification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Biotechnology Reagents (Protein Synthesis and Purification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Biotechnology Reagents (Gene Expression) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Biotechnology Reagents (Gene Expression) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Biotechnology Reagents (DNA and RNA Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Biotechnology Reagents (DNA and RNA Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Biotechnology Reagents (Drug Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Biotechnology Reagents (Drug Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Biotechnology Reagents (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Biotechnology Reagents (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: North America: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: North America: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: United States: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: United States: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Canada: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Canada: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Asia-Pacific: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Asia-Pacific: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: China: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: China: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Japan: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Japan: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: India: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: South Korea: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: South Korea: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Australia: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Australia: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Indonesia: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Indonesia: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Others: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Others: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Europe: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Europe: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Germany: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Germany: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: France: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: France: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United Kingdom: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United Kingdom: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Italy: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Italy: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Spain: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Spain: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Russia: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Russia: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Latin America: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Latin America: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Brazil: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Brazil: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Mexico: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Mexico: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Middle East and Africa: Biotechnology Reagents Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Middle East and Africa: Biotechnology Reagents Market: Breakup by Country (in %), 2024
  • Figure 69: Middle East and Africa: Biotechnology Reagents Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Global: Biotechnology Reagents Industry: Drivers, Restraints, and Opportunities
  • Figure 71: Global: Biotechnology Reagents Industry: Value Chain Analysis
  • Figure 72: Global: Biotechnology Reagents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biotechnology Reagents Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Biotechnology Reagents Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Biotechnology Reagents Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Biotechnology Reagents Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Biotechnology Reagents Market: Competitive Structure
  • Table 6: Global: Biotechnology Reagents Market: Key Players
目次
Product Code: SR112025A8220

The global biotechnology reagents market size reached USD 91,748.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,74,735.4 Million by 2033, exhibiting a growth rate (CAGR) of 7.05% during 2025-2033. The market is experiencing robust growth, driven by increasing investment in research and development (R&D) activities, rising demand in healthcare diagnostics and drug development, the heightened prevalence of chronic diseases and genetic disorders, and rapid technological advancements in production and automation.

Biotechnology reagents play a pivotal role in the field of life sciences, facilitating various research and diagnostic applications. They are vital components used in biotechnology processes to enable the isolation, analysis, and manipulation of biological molecules and systems. They are made through meticulous manufacturing processes and are designed to provide accurate and reliable results, ensuring the progress and success of experiments and investigations. One of the key advantages of biotechnology reagents is their versatility and broad applicability across multiple disciplines within the life sciences. They are utilized in various research areas, such as genomics, proteomics, cell biology, molecular diagnostics, and drug discovery, as they enable scientists to extract and purify deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins, as well as perform assays, detect biomarkers, and conduct gene expression studies. Biotechnology reagents also facilitate the development of new therapeutic drugs, vaccines, and personalized medicines, contributing to advancements in healthcare and the treatment of diseases.

Biotechnology Reagents Market Trends:

The global biotechnology reagents market is bolstered by numerous factors, including the increasing research and development (R&D) activities in the life sciences sector and the growing demand for personalized medicine and targeted therapies. Moreover, the rapid advancements in genomics and proteomics research and the surging prevalence of chronic and infectious diseases are accelerating the market growth. Besides this, the technological advancements in biotechnology and molecular biology and the expansion of pharmaceutical and biotechnology industries are providing an impetus to the market growth. Additionally, the burgeoning investments in healthcare infrastructure and government initiatives and funding for research projects are other growth-inducing factors. In line with this, the escalating collaborations between academic institutions and industry players and growing awareness and adoption of molecular diagnostics are supporting the market growth. Furthermore, the emergence of bioinformatics and computational biology and the expansion of biobanking and biorepository facilities are augmenting the market growth. Other factors, such as the surging demand for high-quality reagents for accurate experimental results, escalating demand for genetically modified organisms (GMOs) in agriculture, and the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, are positively contributing to the market growth.

Key Market Segmentation:

Technology Insights:

  • Life Science Reagents
  • PCR
  • Cell Culture
  • Hematology
  • In-Vitro Diagnostics
  • Others
  • Analytical Reagents
  • Chromatography
  • Mass Spectrometry
  • Electrophoresis
  • Flow Cytometry
  • Others

Application Insights:

  • Protein Synthesis and Purification
  • Gene Expression
  • DNA and RNA Analysis
  • Drug Testing
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for biotechnology reagents. Some of the factors driving the North America biotechnology reagents market included the surging applications of biotechnology in environmental monitoring and remediation, the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, and the expansion of the biotechnology industry.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global biotechnology reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global biotechnology reagents market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biotechnology reagents market?
  • What is the impact of each driver, restraint, and opportunity on the global biotechnology reagents market?
  • What are the key regional markets?
  • Which countries represent the most attractive biotechnology reagents market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the biotechnology reagents market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biotechnology reagents market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biotechnology reagents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biotechnology Reagents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Life Science Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 PCR
      • 6.1.2.2 Cell Culture
      • 6.1.2.3 Hematology
      • 6.1.2.4 In-Vitro Diagnostics
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Analytical Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Chromatography
      • 6.2.2.2 Mass Spectrometry
      • 6.2.2.3 Electrophoresis
      • 6.2.2.4 Flow Cytometry
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Protein Synthesis and Purification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gene Expression
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA and RNA Analysis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Drug Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 SWOT Analysis
    • 13.3.3 Becton Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 bioMerieux SA
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Bio-Rad Laboratories Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Illumina Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Lonza Group AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Merck KGaA
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Meridian Bioscience Inc. (SD Biosensor)
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 SWOT Analysis
    • 13.3.10 PerkinElmer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Promega Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Waters Corporation
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
      • 13.3.13.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.